Rigel Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US7665596034

SecurityRIGL / Rigel Pharmaceuticals, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership131,199 shares
Latest Disclosed Value $ 3,547,621
Citadel Advisors Llc ownership in RIGL / Rigel Pharmaceuticals, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 131,199 shares of Rigel Pharmaceuticals, Inc. (US:RIGL) valued at $3,547,621 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 185,419 shares of Rigel Pharmaceuticals, Inc.. This represents a change in shares of -29.24% during the quarter. The current value of the position is $3,975,330 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (RIGL) in the form of stock options. The firm currently holds call options representing 24,900 of underlying shares valued at $673,296 USD and put options representing 13,000 of underlying shares valued at $351,520 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

RIGL / Rigel Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F RIGEL PHARMACEUTICALS COM 766559702 131,199 -54,220 -29.24 3,548 -55.33 0.0005
2026-02-17 2025-12-31 13F RIGEL PHARMACEUTICALS COM 766559702 185,419 98,955 114.45 7,941 224.25 0.0012
2025-11-14 2025-09-30 13F RIGEL PHARMACEUTICALS COM 766559702 86,464 86,464 2,450 0.0004
2025-05-15 2025-03-31 13F RIGEL PHARMACEUTICALS COM 766559702 0 -28,411 -100.00 0 -100.00
2025-02-14 2024-12-31 13F RIGEL PHARMACEUTICALS COM 766559702 28,411 28,411 478 0.0001
2024-11-14 2024-09-30 13F RIGEL PHARMACEUTICALS COM 766559702 0 -16,208 -100.00 0 -100.00
2024-08-14 2024-06-30 13F RIGEL PHARMACEUTICALS COM 766559702 16,208 16,208 133 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F RIGEL PHARMACEUTICALS COM Call 24,900 -46.57 673 -66.27 n/a n/a n/a
2026-02-17 2025-12-31 13F RIGEL PHARMACEUTICALS COM Call 46,600 94.98 1,996 194.68 n/a n/a n/a
2025-11-14 2025-09-30 13F RIGEL PHARMACEUTICALS COM Call 23,900 65.97 677 151.67 n/a n/a n/a
2025-08-14 2025-06-30 13F RIGEL PHARMACEUTICALS COM Call 14,400 -2.70 270 1.13 n/a n/a n/a
2025-05-15 2025-03-31 13F RIGEL PHARMACEUTICALS COM Call 14,800 -26.00 266 -20.83 n/a n/a n/a
2025-02-14 2024-12-31 13F RIGEL PHARMACEUTICALS COM Call 20,000 52.56 336 58.49 n/a n/a n/a
2024-11-14 2024-09-30 13F RIGEL PHARMACEUTICALS COM Call 13,110 2.58 212 101.90 n/a n/a n/a
2024-08-14 2024-06-30 13F RIGEL PHARMACEUTICALS COM Call 12,780 105 n/a n/a n/a
2016-05-13 2016-03-31 13F RIGEL PHARMACEUTICALS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2015-12-31 13F/A RIGEL PHARMACEUTICALS Cmn Call 1,200 140.00 4 300.00 n/a n/a n/a
2016-02-12 2015-12-31 13F RIGEL PHARMACEUTICALS Cmn Call 1,200 4 n/a n/a n/a
2015-11-16 2015-09-30 13F RIGEL PHARMACEUTICALS Cmn Call 500 -64.29 1 -75.00 n/a n/a n/a
2015-08-14 2015-06-30 13F RIGEL PHARMACEUTICALS Cmn Call 1,400 180.00 4 300.00 n/a n/a n/a
2015-02-17 2014-12-31 13F RIGEL PHARMACEUTICALS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-11-14 2014-09-30 13F RIGEL PHARMACEUTICALS Cmn Call 2,800 100.00 5 0.00 n/a n/a n/a
2014-08-14 2014-06-30 13F RIGEL PHARMACEUTICALS Cmn Call 1,400 -63.16 5 -66.67 n/a n/a n/a
2014-05-15 2014-03-31 13F RIGEL PHARMACEUTICALS Cmn Call 3,800 -24.00 15 7.14 n/a n/a n/a
2014-02-14 2013-12-31 13F RIGEL PHARMACEUTICALS Cmn Call 5,000 31.58 14 0.00 n/a n/a n/a
2013-11-14 2013-09-30 13F RIGEL PHARMACEUTICALS Cmn Call 3,800 -85.33 14 -83.91 n/a n/a n/a
2013-08-14 2013-06-30 13F RIGEL PHARMACEUTICALS Cmn Call 25,900 87 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F RIGEL PHARMACEUTICALS COM Put 13,000 28.71 352 -18.75 n/a n/a n/a
2026-02-17 2025-12-31 13F RIGEL PHARMACEUTICALS COM Put 10,100 -52.80 433 -28.71 n/a n/a n/a
2025-11-14 2025-09-30 13F RIGEL PHARMACEUTICALS COM Put 21,400 606 n/a n/a n/a
2025-08-14 2025-06-30 13F RIGEL PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F RIGEL PHARMACEUTICALS COM Put 8,800 340.00 158 378.79 n/a n/a n/a
2025-02-14 2024-12-31 13F RIGEL PHARMACEUTICALS COM Put 2,000 -68.35 34 -67.65 n/a n/a n/a
2024-11-14 2024-09-30 13F RIGEL PHARMACEUTICALS COM Put 6,320 98.12 102 292.31 n/a n/a n/a
2024-08-14 2024-06-30 13F RIGEL PHARMACEUTICALS COM Put 3,190 -70.46 26 8.33 n/a n/a n/a
2017-01-31 2016-06-30 13F/A RIGEL PHARMACEUTICALS Cmn Put 10,800 -73.72 24 -84.11 n/a n/a n/a
2016-08-12 2016-06-30 13F RIGEL PHARMACEUTICALS Cmn Put 10,800 24 n/a n/a n/a
2016-05-13 2016-03-31 13F RIGEL PHARMACEUTICALS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2015-12-31 13F/A RIGEL PHARMACEUTICALS Cmn Put 10,600 23.26 32 52.38 n/a n/a n/a
2016-02-12 2015-12-31 13F RIGEL PHARMACEUTICALS Cmn Put 10,600 32 n/a n/a n/a
2015-11-16 2015-09-30 13F RIGEL PHARMACEUTICALS Cmn Put 8,600 -59.05 21 -68.66 n/a n/a n/a
2015-08-14 2015-06-30 13F RIGEL PHARMACEUTICALS Cmn Put 21,000 740.00 67 644.44 n/a n/a n/a
2015-05-15 2015-03-31 13F RIGEL PHARMACEUTICALS Cmn Put 2,500 -88.10 9 -86.57 n/a n/a n/a
2014-11-14 2014-09-30 13F RIGEL PHARMACEUTICALS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-08-14 2014-06-30 13F RIGEL PHARMACEUTICALS Cmn Put 400 -83.33 1 -88.89 n/a n/a n/a
2014-05-15 2014-03-31 13F RIGEL PHARMACEUTICALS Cmn Put 2,400 -25.00 9 0.00 n/a n/a n/a
2014-02-14 2013-12-31 13F RIGEL PHARMACEUTICALS Cmn Put 3,200 -84.24 9 -87.67 n/a n/a n/a
2013-11-14 2013-09-30 13F RIGEL PHARMACEUTICALS Cmn Put 20,300 123.08 73 143.33 n/a n/a n/a
2013-08-14 2013-06-30 13F RIGEL PHARMACEUTICALS Cmn Put 9,100 30 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.